🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Cancer Screening

The Development of MASLD Among Survivors of Breast or Colorectal Cancer NCT07280143n/a1 site📍 Bern University of Bern Validation of the Oncoliq Test for the Early Detection of Breast Cancer. NCT07331506n/a1 site📍 Buenos Aires Oncoliq US Inc · Tests: Peripheral blood draw Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer NCT06876610n/a1 site📍 Beijing Geneplus-Beijing Co. Ltd. AI-Assisted Non-Contrast CT for Multi-Cancer Screening NCT06632886NA1 site📍 Shanghai Guo ShiWei · Tests: AI-Assisted Non-Contrast CT for Multi-Cancer Screening Community Services Navigation to Advance Health Equity in Breast Cancer Screening NCT06305312NA1 site📍 Salt Lake City University of Utah · Tests: Community Service Navigation, Usual Care Cardiometabolic Screening Program NCT05386719NA1 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Prescreening, Screening and Enrollment, Baseline, Interpret BMI, Interpret HbA1c An Investigation Into Dielectric Testing for the Evaluation and Characterisation of Breast Tissue Using a Novel Time-Domain Bioimpedance Tool NCT07782814n/a1 site📍 London Zedsen Limited · Tests: TD-BIS scanner Instagram and Podcast Intervention for Breast Cancer Awareness and Screening NCT07673588NA1 site📍 Ankara Ankara University · Tests: Instagram-Based Breast Cancer Awareness Intervention, Instagram-Podcast-Based Breast Cancer Awareness Intervention Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie NCT07357311n/a1 site📍 Paris Institut Curie Screening For BCRL In Targeted Therapy For Breast Cancer NCT05142800n/a1 site📍 Boston Massachusetts General Hospital · Tests: Perometer, SOZO device Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening NCT06898333n/a1 site📍 Creve Coeur Washington University School of Medicine Women Informed to Screen Depending on Measures of Risk (Wisdom Study) NCT02620852NA11 sites📍 Birmingham📍 Irvine📍 Los Angeles University of California, San Francisco · Tests: Complete a health questionnaire, Provide a saliva sample for genetic testing, Screening advice based on a comprehensive… Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer NCT06833502Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: CT Scan MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer NCT06247449NA1 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Brain imaging, Analysis of circulating tumor DNA, Testing Morbidities Index Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners NCT06111417n/a2 sites📍 Dijon📍 Levallois-Perret Centre Georges Francois Leclerc · Tests: Questionnaires, Communication of the results of the BRCA1/2 ultra rapid test Active Mammography and Counseling NCT07238088NA1 site📍 San Juan University of Puerto Rico Comprehensive Cancer Center · Tests: Individual Education, Community Navigation, Healthcare Providers Educational Intervention Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme NCT07734389NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Comprehensive Clinical and Genetic Breast Cancer Risk Assessment Evaluation of the Effect of Using Ultrasound Robots for Breast Cancer Screening: A Multicenter, Parallel-group, Cluster Randomized Controlled Trial NCT07331363NA1 site📍 Xiantao Huazhong University of Science and Technology · Tests: Screening of the subjects was conducted using an ultrasonic robot. Evaluation of the Bexa Breast Examination NCT06643767NA1 site📍 Abilene Sure, Inc. · Tests: Bexa and focus ultrasound AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. NCT02102165NA52 sites📍 Brussels📍 Brussels📍 Charleroi Jules Bordet Institute · Tests: metastatic lesion biopsy Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics NCT05694559NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Genetic Testing and Counseling, Screening Form The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics NCT06760507NA1 site📍 Atlanta Emory University · Tests: Adapted Family History Screening Program Artificial Intelligence in Mammography Screening in Norway NCT06032390NA1 site📍 Oslo Norwegian Institute of Public Health · Tests: AI assisted mammography screening interpretation, Standard mammography screening interpretation Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts NCT05625659NA13 sites📍 Birmingham📍 Boca Raton📍 The Villages American College of Radiology · Tests: Dual-Energy Contrast-Enhanced Spectral Mammography (CESM) Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial NCT06636370NA1 site📍 Utrecht C.H. van Gils · Tests: Contrast-enhanced mammography (CEM), Abbreviated MRI (AB-MRI) CfDNA in Hereditary And High-risk Malignancies 2 NCT06726642n/a8 sites📍 Vancouver📍 St. John's📍 Halifax University Health Network, Toronto · Tests: Cell-free DNA analysis Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings NCT06268405NA1 site📍 Toronto University Health Network, Toronto · Tests: Liquid Biopsy, Positron Emission Mammography (PEM) Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial NCT06629896NA1 site📍 Reggio Emilia Azienda USL Reggio Emilia - IRCCS · Tests: Contrast Enhancement Mammography, magnetic resonance imaging (MRI) and digital mammography (DM) Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening NCT07273357n/a5 sites📍 Gävle📍 Jönköping📍 Kalmar Region Jönköping County
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy